Clinical significance of WT1 mutations in pediatric AML. Kaplan-Meier estimates show that patients with WT1 mutations have shorter (A) OS and (B) EFS from study entry than patients without these mutations. (C) Cumulative incidence of relapse was also worse for patients with WT1 mutations.